Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI

Tarun Singhal, Tanjore K. Narayanan, Martin P. Jacobs, Chandrashekhar Bal and Joseph C. Mantil
Journal of Nuclear Medicine November 2012, 53 (11) 1709-1715; DOI: https://doi.org/10.2967/jnumed.111.102533
Tarun Singhal
1Partners Neurology Program, Massachusetts General Hospital and Brigham and Women’s Hospital, Boston, Massachusetts; and
2Department of Nuclear Medicine/PET, Charles F. Kettering Memorial Hospital, Wright State University, Dayton, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanjore K. Narayanan
2Department of Nuclear Medicine/PET, Charles F. Kettering Memorial Hospital, Wright State University, Dayton, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin P. Jacobs
2Department of Nuclear Medicine/PET, Charles F. Kettering Memorial Hospital, Wright State University, Dayton, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chandrashekhar Bal
2Department of Nuclear Medicine/PET, Charles F. Kettering Memorial Hospital, Wright State University, Dayton, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph C. Mantil
2Department of Nuclear Medicine/PET, Charles F. Kettering Memorial Hospital, Wright State University, Dayton, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (11)
Journal of Nuclear Medicine
Vol. 53, Issue 11
November 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI
Tarun Singhal, Tanjore K. Narayanan, Martin P. Jacobs, Chandrashekhar Bal, Joseph C. Mantil
Journal of Nuclear Medicine Nov 2012, 53 (11) 1709-1715; DOI: 10.2967/jnumed.111.102533

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI
Tarun Singhal, Tanjore K. Narayanan, Martin P. Jacobs, Chandrashekhar Bal, Joseph C. Mantil
Journal of Nuclear Medicine Nov 2012, 53 (11) 1709-1715; DOI: 10.2967/jnumed.111.102533
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Reciprocal links between methionine metabolism, DNA repair and therapy resistance in glioblastoma
  • Methionine Restriction: Ready for Prime Time in the Cancer Clinic?
  • Prognostic Value of the Metabolic and Volumetric Parameters of 11C-Methionine Positron-Emission Tomography for Gliomas: A Systematic Review and Meta-Analysis
  • Methionine and Kynurenine Activate Oncogenic Kinases in Glioblastoma, and Methionine Deprivation Compromises Proliferation
  • Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas
  • 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET in Human Gliomas: Comparative Study with [18F]Fluorodeoxyglucose and L-Methyl-[11C]Methionine PET
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

Keywords

  • gliomas
  • Positron Emission Tomography
  • methionine
  • fluorodeoxyglucose
  • MRI
SNMMI

© 2025 SNMMI

Powered by HighWire